Foundayo™ (orforglipron) — 17.2 mg
- Medicare
- Priced September 27, 2026
Your cheapest verified route right now
verified price- Per year at 12 fills
- $600
Ramp cost calculator
CloseWhat the climb costs
12-month total $600 12 fills
Average per fill $50 peak $50
Flat at 17.2 mg $600 what multiplying today's price gives you
- 0.8 mg 1×
- 2.5 mg 3×
- 5.5 mg 4×
- 9 mg 2×
- 14.5 mg 1×
- 17.2 mg 1×
- Jan 1 LillyDirect self-pay — Foundayo™ (orforglipron) 2.5 mg moves to $199/month
- Already priced into the totals above — each fill uses the price in force on its own date. See the changelog
Fills at each dose on the way up
Reset to the label minimumMinus stops at the label's minimum interval — this never shows a schedule faster than the manufacturer's. Staying longer on a dose is yours to choose.
Every fill, dated and priced (12)
- 1 Sep 27, 2026 0.8 mg Medicare GLP-1 Bridge $50
- 2 Oct 27, 2026 2.5 mg Medicare GLP-1 Bridge $50
- 3 Nov 26, 2026 2.5 mg Medicare GLP-1 Bridge $50
- 4 Dec 26, 2026 2.5 mg Medicare GLP-1 Bridge $50
- 5 Jan 25, 2027 5.5 mg Medicare GLP-1 Bridge $50
- 6 Feb 24, 2027 5.5 mg Medicare GLP-1 Bridge $50
- 7 Mar 26, 2027 5.5 mg Medicare GLP-1 Bridge $50
- 8 Apr 25, 2027 5.5 mg Medicare GLP-1 Bridge $50
- 9 May 25, 2027 9 mg Medicare GLP-1 Bridge $50
- 10 Jun 24, 2027 9 mg Medicare GLP-1 Bridge $50
- 11 Jul 24, 2027 14.5 mg Medicare GLP-1 Bridge $50
- 12 Aug 23, 2027 17.2 mg Medicare GLP-1 Bridge $50
This is arithmetic, not a plan. Fills are spaced 30 days apart — the label's own supply length — and priced on the date each one falls, so dated price changes are already included. Your prescriber decides whether you step at all, and many people stay at a lower dose.
The label's own words (once daily)
Initiate at 0.8 mg once daily. Increase to 2.5 mg after at least 30 days, then to 5.5 mg after at least 30 days. The dosage may then be increased to 9 mg, 14.5 mg or 17.2 mg after at least 30 days on the current dosage. Maximum 17.2 mg once daily.
Verified Sep 4, 2026 ·uspl.lilly.com
Every route we can price
Verified prices outrank cheaper estimates. Reference rows inform, never win.
- Rank 1
Medicare GLP-1 Bridge
until Dec 31, 2027$50/mo- All Foundayo formulations covered
- Runs OUTSIDE the Part D plan (central processor: Humana, BIN 028918 / PCN MEDDGLP1BR). Not available if your Part D plan already covers a GLP-1 for you, or if you have T2D, moderate-to-severe OSA, or noncirrhotic MASH (those route through standard Part D). Filling any GLP-1 through your Part D plan after you are approved ends your Bridge eligibility for good — the next Bridge refill is rejected at the counter — and so does moving to a Part D plan type the Bridge does not cover. A prescriber must attest on the prior authorization that you met a BMI category: BMI >= 35; or >= 30 with heart failure with preserved ejection fraction, uncontrolled hypertension, or chronic kidney disease stage 3a or above; or >= 27 with pre-diabetes, prior myocardial infarction, prior stroke, or symptomatic peripheral artery disease. That BMI is the one you had when you STARTED GLP-1 therapy, not the one you have now — losing weight since does not disqualify you. The copay does not count toward the Part D deductible or your out-of-pocket maximum, and no coupons apply. There is no low-income subsidy — LIS beneficiaries pay it in full.
Verified Sep 4, 2026 · cms.gov
- Rank 2
LillyDirect self-pay
$299/moRises to $349/month if the refill condition is missed.
- Refill within 45 days to keep this price
- If you refilled within 45 days but were charged $349 because Lilly could not verify the refill at the counter, you can claim the difference back; claims close March 31, 2027
- Lilly's direct channel. Vial and KwikPen at identical self-pay prices at every tier. Telehealth not included.
Verified Sep 5, 2026 · foundayo.lilly.com
- Rank 3
Discount card at retail (GoodRx and similar)
verify locally$149/mo- Starting-at price announced when GoodRx opened the channel; GoodRx publishes no per-dose ladder above it
- Dose- and pharmacy-dependent. Verify at your ZIP before relying on it.
Verified Sep 4, 2026 · investors.goodrx.com
Share or post this breakdown
Markdown Summary